NeoGenomics, Inc. (NASDAQ:NEO) | WebDisclosure

Basculer en Français

8600	Companies
140497	Keywords
76472	Articles
75069	Press releases

Home
Companies
NeoGenomics, Inc.

PRESS RELEASE

published on 12/28/2023 at 14:10, 1 year 3 months ago

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE

published on 12/05/2023 at 14:00, 1 year 4 months ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE

published on 11/14/2023 at 13:00, 1 year 4 months ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE

published on 11/06/2023 at 22:05, 1 year 5 months ago

NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE

published on 10/24/2023 at 13:00, 1 year 5 months ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE

published on 10/17/2023 at 15:20, 1 year 5 months ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Accesswire

Published on 04/07/2025 at 00:05, 6 hours 45 minutes ago

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 05:50, 2 days 1 hour ago

Lobe Sciences Provides Corporate Update
Published on 04/05/2025 at 01:50, 2 days 5 hours ago

Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/05/2025 at 01:00, 2 days 5 hours ago

AIML Announces Proposed Private Placement
Published on 04/05/2025 at 00:15, 2 days 6 hours ago

UniDoc Announces LIFE Offering

View all ACCESSWIRE

EQS Group

Published on 04/06/2025 at 18:20, 12 hours 29 minutes ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 15 hours 41 minutes ago

EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 11 hours ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/04/2025 at 18:51, 2 days 11 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/04/2025 at 18:30, 2 days 12 hours ago

Forbo shareholders approved all proposals of the Board of Directors

Les Echos

Published on 04/04/2025 at 19:18, 2 days 11 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 11 hours ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 12 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:17, 2 days 12 hours ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 31 mars et le 3 avril 2025
Published on 04/04/2025 at 18:13, 2 days 12 hours ago

Total number of voting rights and shares making up the share capital at March 31, 2025

View all LES ECHOS COMFI WIRE